Free tool
Healthcare stocks
We cover 572 companies in the Healthcare sector. The median market value in the group is $91.60M. Across the group, the median move over the past trading day is +0.15%. 47% of the 553 with a 200-day average trade above it. Price change over the past year runs from −62.9% to +59.3% across the middle 80 percent of the group, with a median of −9.2%. Across the group, 4 companies currently carry a tier A volume signal.
Other lists in this group
Table
572 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| POLAR.ST | PolarCool AB (publ) | 1.73 SEK | +8.12% | −55.87% | −67.96% |
| GABA.ST | Gabather AB (publ) | 0.03 SEK | +10.00% | +6.94% | −17.20% |
| VSD-B.ST | Vibrosense Dynamics AB (publ) | 0.70 SEK | +16.33% | −27.14% | −58.08% |
| PHAL.ST | PharmaLundensis AB | 0.32 SEK | 0.00% | +8.19% | +37.83% |
| ADV.WA | Adiuvo Investments S.A. | 0.53 PLN | +13.49% | −7.34% | −34.08% |
| RESP.ST | Respiratorius AB (publ) | 2.28 SEK | +3.17% | +31.03% | −39.20% |
| ATORX.ST | Alligator Bioscience AB (publ) | 0.03 SEK | −32.46% | −91.74% | −99.27% |
| IMS.ST | Invent Medic Sweden AB (publ) | 0.10 SEK | +6.95% | −69.51% | −22.48% |
| 27N0.DE | Cannovum Cannabis AG | 0.56 EUR | +10.76% | +24.94% | +22.47% |
| BIG1.DE | Bio-Gate AG | 2.83 EUR | −14.39% | +262.18% | +200.53% |
| APTA.ST | Aptahem AB (publ) | 0.56 SEK | −15.96% | −51.69% | −67.65% |
| MONI.ST | Monivent AB | 0.17 SEK | −5.71% | −49.39% | −37.02% |
| NANECH.ST | NanoEcho AB (publ) | 0.03 SEK | −3.51% | −57.96% | −72.03% |
| CHLL.L | Chill Brands Group PLC | 2.00 GBP | −9.09% | −74.19% | −87.88% |
| ALINT.PA | IntegraGen SA | 0.18 EUR | −18.86% | +32.22% | −36.25% |
| 2CUREX.ST | 2cureX AB (publ) | 0.66 SEK | −62.67% | +22.68% | −71.79% |
| ODIN.ST | Odinwell AB (publ) | 0.14 SEK | −25.80% | −50.71% | −61.25% |
| PTP.DE | Pentixapharm Holding AG | 1.85 EUR | −5.61% | +20.13% | +5.47% |
| LXB.ST | Luxbright AB (publ) | 0.06 SEK | −42.86% | −88.33% | −91.76% |
| MAGLE.ST | Magle Chemoswed Holding AB (publ) | 0.40 SEK | −25.93% | −97.66% | −98.15% |
| ISAB.ST | Inhalation Sciences Sweden AB (publ) | 0.14 SEK | −35.19% | −70.34% | −73.58% |
| TRLS.L | Trellus Health plc | 0.04 GBP | +3233.33% | −90.00% | −94.29% |
| S2M.ST | S2Medical AB (publ) | 0.00 SEK | −11.11% | −52.00% | −63.08% |
| NIDHOG.ST | Nidhogg Resources Holding AB (publ) | 0.47 SEK | +16.75% | −41.99% | −72.69% |
| ALSAF.PA | Safe Orthopaedics SA | 0.64 EUR | 0.00% | −61.90% | −73.33% |
| SDET.ST | SensoDetect Aktiebolag (publ) | 0.00 SEK | −27.27% | −97.75% | −99.53% |
| ALNEV.PA | Neovacs S.A. | 0.55 EUR | −31.22% | +6150.00% | −11.29% |
| 0VQ.DE | PureTech Health plc | 1.35 EUR | 0.00% | −12.90% | +1.50% |
| 6IV.DE | Inventiva S.A. | 4.08 EUR | +3.68% | +0.87% | −33.03% |
| ADXN.SW | Addex Therapeutics Ltd | 0.03 CHF | −37.38% | −51.32% | −55.21% |
| AEVS.SW | Aevis Victoria SA | 12.55 CHF | −5.64% | −5.28% | −5.64% |
| ALC.SW | Alcon Inc. | 58.72 CHF | +2.77% | −7.14% | −7.46% |
| ASCN.SW | Ascom Holding AG | 5.37 CHF | +3.47% | +46.58% | +22.28% |
| BANB.SW | Bachem Holding AG | 77.15 CHF | +4.82% | +33.69% | +21.34% |
| BION.SW | BB Biotech AG | 56.70 CHF | +8.21% | +37.62% | +84.12% |
| BIOV.SW | BioVersys AG | 25.20 CHF | −6.67% | +6.33% | −9.03% |
| BSLN.SW | Basilea Pharmaceutica AG | 65.30 CHF | +24.62% | +19.82% | +40.88% |
| CLTN.SW | COLTENE Holding AG | 47.35 CHF | −7.52% | −10.43% | −5.26% |
| COPN.SW | Cosmo NV | 57.80 CHF | −6.17% | −43.92% | −5.27% |
| CURN.SW | Curatis Holding AG | 19.00 CHF | −11.21% | +45.59% | +65.22% |
| DOCM.SW | DocMorris AG | 10.26 CHF | −3.12% | +71.29% | +55.34% |
| EVT.SW | Evotec SE | 3.15 CHF | −32.01% | −45.89% | −45.89% |
| GALD.SW | Galderma Group AG | 171.00 CHF | −3.44% | +7.04% | +22.58% |
| GALE.SW | Galenica AG | 83.35 CHF | −5.55% | −12.83% | +0.15% |
| GXI.SW | Gerresheimer AG | 25.28 CHF | −1.71% | +2.10% | +2.10% |
| IDIA.SW | Idorsia Ltd | 5.68 CHF | −13.09% | +39.78% | +108.64% |
| IMP-A-SDB.ST | Implantica AG | 58.00 SEK | −1.69% | +12.19% | −20.44% |
| KURN.SW | Kuros Biosciences AG | 21.42 CHF | −9.01% | −19.72% | −15.07% |
| LONN.SW | Lonza Group AG | 587.80 CHF | +2.26% | +10.90% | +4.28% |
| MED.SW | Medartis Holding AG | 88.50 CHF | −1.12% | +5.11% | +0.91% |
| METN.SW | Metall Zug AG | 819.00 CHF | +4.07% | −1.80% | −13.79% |
| MMTX.SW | MindMaze Therapeutics Holding SA | 0.16 CHF | −17.85% | −89.73% | −84.98% |
| MOLN.SW | Molecular Partners AG | 3.41 CHF | +4.92% | +0.59% | +14.05% |
| MOVE.SW | Medacta Group SA | 127.40 CHF | −7.55% | −18.95% | −10.60% |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% |
| NWRN.SW | Newron Pharmaceuticals S.p.A. | 12.48 CHF | +8.15% | −51.06% | +44.78% |
| PPGN.SW | PolyPeptide Group AG | 43.95 CHF | +0.23% | +83.13% | +57.25% |
| RDC.SW | Redcare Pharmacy NV | 58.10 CHF | −7.92% | −4.75% | −4.75% |
| RO.SW | Roche Holding AG | 379.00 CHF | +1.99% | +17.47% | +41.81% |
| ROP.SW | Roche Holding AG | 373.80 CHF | +3.35% | +18.35% | +47.60% |
| SANN.SW | Santhera Pharmaceuticals Holding AG | 15.70 CHF | +9.79% | +29.32% | +13.44% |
| SDZ.SW | Sandoz Group AG | 73.54 CHF | +9.01% | +30.08% | +47.80% |
| SFZN.SW | Siegfried Holding AG | 74.45 CHF | −3.25% | +0.18% | −11.23% |
| SHLTN.SW | SHL Telemedicine Ltd. | 1.07 CHF | −0.93% | −9.32% | −32.49% |
| SKAN.SW | SKAN Group AG | 65.70 CHF | +9.87% | +26.45% | +6.80% |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% |
| STMN.SW | Straumann Holding AG | 91.54 CHF | −10.52% | −1.85% | −2.20% |
| T9G.DE | Vidac Pharma Holding Plc | 0.42 EUR | −9.94% | −38.68% | −38.68% |
| TECN.SW | Tecan Group AG | 193.30 CHF | +4.20% | +48.97% | +19.14% |
| VBSN.SW | IVF Hartmann Holding AG | 130.00 CHF | +2.36% | −5.21% | −3.15% |
| XLS.SW | Xlife Sciences AG | 14.75 CHF | −11.68% | −41.24% | −28.40% |
| YPSN.SW | Ypsomed Holding AG | 407.20 CHF | +4.36% | +24.15% | +4.01% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.